DSCG eye drops in allergic rhino-conjunctivitis.
Thirty patients with allergic rhinoconjunctivitis were treated with eye drops containing 2% DSCG during the pollen season of 1977. Sixteen patients were treated with active substance and 14 with placebo. The results show a statistically significant difference in favour of the DSCG drops. DSCG in eye drops seems to be a valuable complement to the drugs available today for the treatment of allergic rhinoconjunctivitis.
D002986:Clinical Trials as Topic; D003231:Conjunctivitis / Q000188:drug therapy*; D004205:Cromolyn Sodium / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004311:Double-Blind Method; D004341:Drug Evaluation; D006801:Humans; D009883:Ophthalmic Solutions; D006255:Rhinitis, Allergic, Seasonal / Q000150:complications / Q000188:drug therapy*
D009883:Ophthalmic Solutions; D004205:Cromolyn Sodium